HighMark Wealth Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
HighMark Wealth Management's CDNA Position: Q2 2026 in Review
HighMark Wealth Management sold out of CareDx (CDNA) in Q2 2026, closing a stake of 475 shares — an estimated $8.25K sold.
HighMark Wealth Management first reported a position in CDNA in Q2 2020 and held it in 24 quarters. The position peaked at $2.47M in Q2 2021. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- HighMark Wealth Management reported no remaining CareDx position as of Q2 2026 after selling out during the quarter.
- HighMark Wealth Management sold 475 CareDx shares in Q2 2026, an estimated $8.25K.
- HighMark Wealth Management first reported a position in CareDx in Q2 2020 and held it in 24 quarters.
- HighMark Wealth Management's CareDx position peaked at $2.47M in Q2 2021.
- 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.